Total anomalous pulmonary venous connection overview

Jump to navigation Jump to search


Total anomalous pulmonary venous connection Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Total anomalous pulmonary venous connection from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

MRI

CT

Echocardiography

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Case Studies

Case #1

Total anomalous pulmonary venous connection overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Total anomalous pulmonary venous connection overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Total anomalous pulmonary venous connection overview

CDC on Total anomalous pulmonary venous connection overview

Total anomalous pulmonary venous connection overview in the news

Blogs on Total anomalous pulmonary venous connection overview

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Total anomalous pulmonary venous connection overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maheep Singh Sangha, M.B.B.S. Sahar Memar Montazerin, M.D.[2]

Overview

Total anomalous pulmonary venous connection (TAPVC) is a rare cyanotic congenital heart defect (CHD) in which all four pulmonary veins are malpositioned and make anomalous connections to the systemic venous circulation. (Normally, pulmonary venous return carries oxygenated blood to the left atrium and to the rest of the body). A patent foramen ovale or an atrial septal defect must be present in order to allow systemic blood flow.

Historical Perspective

Total anomalous pulmonary venous connection was first described by Dr. Winslow, in 1739. The first description of the anatomic characteristics of total anomalous pulmonary venous connection was done by Dr. Brody in 1942. Anatomic description was further completed by another article authored by Dr. Darling in 1957. The first antemortem diagnosis was made in 1950. The first successful surgical repair was performed by Dr. Lewis, surgeon, in 1956.

Classification

Total anomalous venous connection (TAPVC) is classified into four subtypes based on the location of pulmonary venous drainage. These subtypes include, supracardiac, cardiac, infracardiac, and mixed. Supracardiac (type I) is the most common form. Pulmonary venous obstruction is usually seen in infracardiac subtype though. Smith classification is another system that classified this disorder to two categories based on the presence of pulmonary obstruction and the location of anastomosis in relation to diaphragm.

Pathophysiology

In patients of Total anomalous pulmonary venous connection (TAPVC) there is a mixing of oxygenated pulmonary venous blood with deoxygenated blood from systemic circulation.

Causes

Like many other congenital heart defects, the exact cause of total anomalous pulmonary venous connection is not known. Few factors like genetics, maternal alcohol syndrome and some drugs have been found to occur with increased frequency.

Differential Diagnosis

Total anomalous pulmonary venous connection should be differentiated from other cyanotic congenital heart diseases found in the pediatrics population. These disorders include tetralogy of Fallot, persistent truncus arteriosus, transposition of the great vessels, tricuspid atresia, trilogy of Fallot, and pentalogy of Fallot.

Epidemiology and Demographics

Total anomalous pulmonary venous connection is a rare cyanotic congenital heart disease and occurs in 6 to 12 per 100,000 live births.

Risk Factors

There are certain factors that increase the risk of congenital heart diseases, including maternal obesity, medication during pregnancy, alcohol and drugs, rubella during pregnancy, diabetes during pregnancy, and genetic factors.

Screening

There is insufficient evidence to recommend routine screening for total anomalous pulmonary venous connection.

Natural History, Complications and Prognosis

The natural history of untreated patients of TAPVC is not very favorable. It depends on the type of obstruction and amount of shunting across the atrium.

Diagnosis

History and Symptoms

The clinical features in total anomalous pulmonary venous connection depend on the type of anatomic variant present in the patient. This, in turn, determines the amount of mixing between the pulmonary and systemic circulation. In patients with obstructed TAPVC, pulmonary venous circulation drains into the systemic venous circulation. This causes increased returns to the right side of the heart and pulmonary hypertension that can manifest as cyanosis, dyspnea, pulmonary edema, respiratory failure, shock, and hypotension. In patients with unobstructed TAPVC clinical findings are quite similar to conditions with left-to-right shunting like dyspnea, difficulties in feeding, and failure to thrive.

Physical Examination

The physical findings depend on the degree of obstruction and the degree of left-to-right shunting. Physical examination of patients may be remarkable for a decreased pulse, hypotension, tachypnea, peripheral edema, S3 gallop, diastolic murmur due to tricuspid regurgitation, hepatomegaly, and cyanosis.

Laboratory Findings

There are no particular laboratory findings associated with the total anomalous pulmonary venous connection, however, hypoxia, acidosis, and hypercarbia may be observed in severe cases.

Electrocardiogram

Electrocardiography findings are not very specific. However, they can show changes due to the dilatation of the right side of the heart. Possible findings include tall P wave, right axis deviation, and ST changes corresponding to right ventricular hypertrophy.

X-ray

The findings on chest radiography vary depending on the type of anatomic variant of total anomalous pulmonary venous connection (TAPVC). Snowman sign is considered pathognomonic for the diagnosis of total anomalous pulmonary venous connection.

MRI

Magnetic resonance imaging can be helpful as a diagnostic tool in conditions where the echocardiographic findings are inconclusive.

CT

Computed tomography can be helpful as a diagnostic tool in conditions where the echocardiographic findings are inconclusive.

Echocardiography

2D echocardiography along with doppler ultrasonography is a useful tool to diagnose total anomalous pulmonary venous connection.

Other Imaging Findings

In patients with total anomalous pulmonary venous connection, cardiac catheterization can be used as a diagnostic and therapeutic modality. However, with the availability of better non-invasive tools the use of these are decreasing.

Treatment

Medical Therapy

Medical therapy are primarily used to stabilize the patient of total anomalous pulmonary venous connection.

Surgery

Surgery is the mainstay of treatment in total anomalous pulmonary venous connection and should be performed as soon as possible. The surgical procedure varies depending upon the anatomy of the TAPVC lesion.

Template:WH Template:WS